Dawn Scientific Pharmaceuticals, LLC

United States of America

Back to Profile
1-1 of 1 for Dawn Scientific Pharmaceuticals, LLC Sort by
Query
Aggregations
IPC Class
A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 1
C07C 13/48 - Completely or partially hydrogenated naphthalenes 1
C07C 63/74 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings containing halogen having unsaturation outside the aromatic rings 1
Found results for  patents

1.

BEXAROTENE DERIVATIVES AND THEIR USE IN TREATING CANCER

      
Application Number US2019020298
Publication Number 2019/169270
Status In Force
Filing Date 2019-03-01
Publication Date 2019-09-06
Owner DAWN SCIENTIFIC PHARMACEUTICALS, LLC (USA)
Inventor
  • Tsai, Donald
  • Kaelin, David

Abstract

This disclosure relates to compositions and methods for treating cancer. Specifically, this disclosure relates to bexarotene derivatives, methods for treating cancer, autoimmune disorders, and/or skin dermatitis, and/or methods for increasing peripheral blood counts and/or improving immune system function.

IPC Classes  ?

  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • C07C 13/48 - Completely or partially hydrogenated naphthalenes
  • C07C 63/74 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings containing halogen having unsaturation outside the aromatic rings